Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bartlett who wrote (7728)	9/27/2001 9:46:56 AM
From: Cal Gary	Read Replies (1) \| Respond to of 14101

Mark, somewhat related, FDA, HIV and a test device. Perhaps OXO can do a marketing JV with these guys in the future, LOL. Lifted from: Message 16419495 FDA OKs Visible Genetics' HIV Genotyping System 26 Sep 19:07 NEW YORK -(Dow Jones)- Visible Genetics Inc. (VGIN) received approval from the U.S. Food and Drug Administration to market its Trugene HIV-1 Genotyping Kit and OpenGene DNA sequencing system. In a press release Wednesday, the company said this is the first HIV drug resistance test to receive clearance from the FDA. Toronto-based Visible Genetics submitted its Trugene HIV-1 Genotyping Kit and OpenGene system to the FDA on Sept. 5, 2000 as an "integrated system" comprised of the chemistry, hardware, software and interpretive patient report necessary to generate test results. The report provides information to the physician about which antiretroviral drugs are likely to be effective in treating the HIV infection of an individual patient, the company said. ------------------------------------------------------------------------ Conference call on VGIN approval today too: Visible Genetics Inc. Invites You to Join Its Conference Call on the Web Discussing the FDA Clearance for Its TRUGENE HIV-1 Genotyping Test TORONTO, Sept. 27 /PRNewswire/ -- Visible Genetics Inc. (Nasdaq: VGIN - news) invites you to listen to its conference call that will be broadcast live over the Internet on September 27, 2001 at 11:00 AM Eastern Time with Richard T. Daly, President and CEO of Visible Genetics Inc. What: Visible Genetics Receives FDA Clearance of TRUGENE HIV-1 Genotyping Test When: September 27th at 11:00 AM Eastern Time Where: videonewswire.com How: Live over the Internet -- Simply log on to the web at the address above Contact: Bruno Maruzzo 416-813-3271 bruno@visgen.com Visible Genetics Inc. is a leader in the emerging field of pharmacogenomics, which uses genetic information in the identification and analysis of genes to improve patient care and reduce healthcare costs. VGI manufactures and markets high performance automated DNA sequencing systems and complete kits for the analysis of genes linked to disease. The Company's OpenGene(TM) system employs patented CLIP technology -- a single-step, bi-directional sequencing method that significantly reduces the time and cost involved in identifying clinically relevant genetic information.